Presenter: Joshua M. Thurman
Joshua M. Thurman, MD is the Temple Hoyne Buell Professor of Medicine in the Division of Nephrology and Hypertension at the University of Colorado, where he is Director of the Glomerulonephritis Program. His laboratory studies the underlying causes of auto-immunity and inflammation of the kidney, and his lab has developed several novel anti-inflammatory therapeutic agents. Projects are also underway that explore the link between inflammation and cancer. Dr. Thurman’s laboratory has also developed novel radiologic probes to detect and monitor renal inflammation by magnetic resonance imaging (MRI) and positron emission tomography (PET).
Dr. Thurman oversees the Glomerulonephritis Clinic at the University of Colorado Hospital. The Glomerulonephritis Clinic cares for patients with all forms of inflammatory kidney disease, and also participates in clinical trials of new therapies and diagnostic tools for treating these diseases.
Presenter: Dr. Christopher Patriquin
Dr. Christopher Patriquin completed his MD degree and Internal Medicine residency at the University of Western Ontario. He then attended McMaster University for hematology, where he subsequently stayed on as a Clinical Scholar in complement-mediated disease. His primary clinical interests include the thrombotic microangiopathies (TMA) and paroxysmal nocturnal hemoglobinuria (PNH), and his M.Sc. in health research methodology focused on clinical trial and observational methods for studying rare diseases. In 2015, Dr. Patriquin completed honorary clinical research fellowships in the United Kingdom in TMA (University College London) and PNH (NHS National PNH Service, Leeds).
Dr. Patriquin is a member of the Canadian Apheresis Group’s TMA working group, a member of the American Society for Apheresis TMA Subcommittee, Chair for the Canadian PNH Network, and Canadian national coordinator for the International PNH Registry. In 2018, he joined the University Health Network as Assistant Professor of Medicine, where he is a consultant in hematology and apheresis medicine.
Presenter: Dr. Michael Mengel
Dr. Mengel is Chair and Clinical Department Head for Laboratory Medicine and Pathology at the University of Alberta and with Alberta Health Services in Edmonton, Canada. As a sub-specialized Transplantation and Renal Pathologist, Dr. Mengel is engaged in various international sub-specialty societies related to nephropathology and organ transplantation: Past Chair Transplant Diagnostics Community of Practice in the American Society of Transplantation; Board member with International Banff Foundation for Allograft Pathology; President of the Canadian Society of Transplantation; Board member with the Renal Pathology Society.
He studied medicine at the Semmelweiss University in Budapest, Hungary before going on to specialise in pathology and further in transplantation pathology and nephropathology. Before moving to Edmonton, he provided transplant pathology service at the Hannover Medical School, Germany. Dr. Mengel has published widely in his field and his current work is focused on applying molecular techniques to biopsy specimens, with the aim to increase diagnostic precision in organ transplantation.
Presenter: Dr. Ed Conway
Ed Conway was born and educated in Toronto, receiving degrees in Electrical Engineering and Medicine at the University of Toronto. He completed his clinical and research fellowships in Hematology-Oncology at Harvard University and at MIT and returned to Toronto as a physician-scientist and hematologist, establishing a successful research group in vascular biology, funded by the Heart and Stroke Foundation.
In 1995, Ed was recruited to the University of Leuven and the Flanders Institute for Biotechnology (VIB) in Belgium, where he joined the faculty of the Vesalius Research Center. In addition to leading a research group focused on delineating mechanisms underlying vascular diseases, he coordinated collaborations with industry, and organized graduate educational programs.
Ed was repatriated back to Canada in 2009 as the Director of UBC’s Centre for Blood Research in Vancouver, where his goal is to catalyze translational research between basic and clinical scientists and to promote the development of education and training programs for the next generation of medical scientist health professionals. His research is designed to characterize the interplay between the vascular endothelium, coagulation and complement using a range of technologies, from bench to bedside. He is supported by grants from the Heart and Stroke Foundation, the CIHR, NSERC, CFI and the CRC program.
Presenter: Dr. Paul Isenring
Nephrologist at the L’Hôtel-Dieu de Quebec Hospital. Received a Ph.D. in Molecular Physiology from Yale University. Professor of medicine at Laval University. Involved in basic science research 70% and clinical nephrology 30%. Main interests: molecular physiology of renal ion transport, electrolyte disorders, molecular genetics of renal diseases. Funded by CIHR and KFOC for his studies. Member of CIHR and KFOC review grant committees. Over 70 articles and reviews mostly as senior author.